Craig A. Johnson, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 250 shares at $15.20 ($4K) on 2021-06-21, disclosed to the SEC on 2021-06-22.
Scheduled sale ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HRTX | SELL | 2021-04-07 | $4K | — | Filing → |
| MRTX | SELL | 2021-01-25 | $6.3M | — | Filing → |
| ODT | BUY | 2020-12-31 | $51K | — | Filing → |